Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Adenocarcinoma × spartalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 24 Melanoma 22 Neoplasm Metastasis 19 Colorectal Neoplasms 18 Carcinoma, Hepatocellular 18 Pancreatic Neoplasms 14 Triple Negative Breast Neoplasms 12 Neoplasms 12 Nasopharyngeal Carcinoma 12 Stomach Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Carcinoma, Renal Cell 10 Rectal Neoplasms 8 Lymphoma 8 Uterine Cervical Neoplasms 7 Locally Advanced Rectal Cancer 7 Esophageal Neoplasms 7 Lung Neoplasms 6 Breast Neoplasms 6 Recurrence 5 Ovarian Neoplasms 5 Lymphoma, Extranodal NK-T-Cell 5 Liver Neoplasms 5 Glioblastoma 5 Endometrial Neoplasms 5 Advanced Solid Tumor 5 Sarcoma 4 Head and Neck Neoplasms 4 Gastrointestinal Stromal Tumors 4 Esophageal Squamous Cell Carcinoma 4

Interventions

spartalizumab 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06728657 2025-06-18

TORCH-G

Fudan University

Phase 2 Suspended

Gastrointestinal

Stomach Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡